Modernizing FDA’s Regulationof Over-the-Counter Drugs Witnesses Dr. Janet Woodcock Director, Food and Drug Administration, Center for Drug Evaluation and Research Witness Statement Truth in Testimony and CV Dr. Bridgette Jones Chair, Committee on Drugs, American Academy of Pediatrics Witness Statement Truth in Testimony and CV Mr. Scott Melville President and CEO, Consumer Healthcare Products Association Witness Statement Truth in Testimony and CV Ms. Kirsten Moore Project Director, The Pew Charitable Trusts, Health Care Products Witness Statement Truth in Testimony and CV Mr. Gil Roth President, Pharma and Biopharma Outsourcing Association Witness Statement Truth in Testimony and CV Mr. Michael Werner Partner, Holland and Knight, on behalf of the Public Access to SunScreens (PASS) Coalition Witness Statement Truth in Testimony and CV Documents Hearing Notice Background Memo Hearing Attendance Preliminary Transcript Opening Statement – Health Subcommittee Chairman Burgess Opening Statement – Full Committee Chairman Walden Document for the Record – Rep. Lance – GSK Letter Opening Statement – Full Committee Ranking Member Pallone Text of Legislation H.R. __, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2017 Subcommittees Health (115th Congress) Health hearing